- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02695251
AGE - Functional Reserve (AGE-FR)
Renal Hemodynamic, Functional and Metabolic Changes After AGEs (Advanced Glycation End Products) Load by Positron Emission Tomography (PET) and Blood Oxygen Level-Dependent (BOLD) - MRI. The AGE- Functional Reserve Study.
Renal functional reserve is defined as the glomerular hyper filtration induced by a protein load. Renal blood flow and Glomerular Filtration Rate (GFR) increase in response to a protein load. Renal functional reserve loss is associated with a persistent hyper filtration state, seen in first stages of diabetic nephropathy, leading to progression of Chronic Kidney Disease (CKD). This observation has lead to larger clinical studies that demonstrated the positive effects of protein restriction on kidney function, and allowed the scientific community to recommend low proteins diet (less than 0.8 g / kg/ day) to prevent CKD progression. Nevertheless, the precise mechanisms responsible for kidney hemodynamic and metabolic changes induced by a protein load, are debated. Uribarri et al have suggested that renal hemodynamic changes induced by a protein load are mainly due to the Advanced Glycation End Products (AGEs) content. Indeed, initial studies experimental conditions leading to the demonstration of renal functional reserve (amino acid or protein perfusion or cooked meat), were in fact responsible for an AGEs load, based on recent published data.
The aim of this study is to determine whether AGEs alone or proteins in general are responsible for the mobilization of renal functional reserve, leading to the progression of CKD.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69437
- Service de Néphrologie - Hôpital Edouard Herriot
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy males subjects
- age between 18 and 30 years old
Exclusion Criteria:
- Kidney disease
- Diabetes
- Obesity
- Hypertension
- Non Steroidal Anti Inflammatory Drug treatment (NSAIDS)
- MRI Contra indications
- Myeloma
- High basal Radiation exposure : more than 1 milliSievert (mSv) in the last 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low AGE meal
Renal functional parameters are measured at baseline and after a low AGE (eggs) meal
|
Patients will receive a low AGE (eggs) meal
|
|
Experimental: High AGE meal
Renal functional parameters are measured at baseline and after a high (mixed nuggets) AGE (eggs) meal
|
Patients will receive a high (mixed nuggets) AGE (eggs) meal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Renal Blood Flow
Time Frame: 120 minutes after meal
|
Differences in Renal blood flow will be assessed 120 minutes after 2 different meals, either high AGE (mixed nuggets) or low AGE meal (mixed eggs), with PET- MRI using 150 labeled water.
|
120 minutes after meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
renal oxygen content
Time Frame: 120 minutes after meal
|
Differences in renal oxygen content will be assessed after either a high or low AGE meal with BOLD (Blood Oxygen Level Dependant) - MRI
|
120 minutes after meal
|
|
renal oxidative metabolism
Time Frame: 120 minutes after meal
|
Differences in renal oxidative metabolism will be assessed after either a high or low AGE meal with PET MRI using 11C labeled - Acetate
|
120 minutes after meal
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laurent JUILLARD, MD, PhD, Hospices Civils de Lyon
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL15_0122
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Function Tests
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalActive, not recruiting
-
Xiangya Hospital of Central South UniversityRecruitingCardiopulmonary Function | Respiratory Function Tests,Heart Function TestsChina
-
University of ZurichCompleted
-
Federal University of Mato GrossoCompletedRespiratory Function Tests
-
Cliniques universitaires Saint-Luc- Université...CompletedSpirometry | Respiratory Function TestsBolivia
-
University of MichiganLexicon PharmaceuticalsRecruitingPlatelet Function and Reactivity TestsUnited States
-
Fakultas Kedokteran Universitas IndonesiaNot yet recruitingAcute Kidney Injury | Acetylcysteine Adverse Reaction | Kidney Function Tests | Cancer (Solid Tumors) | Kidney Function Issue
-
Ankara City Hospital BilkentRecruitingProstatectomy | Kidney Function Tests | Neutrophil Gelatinase-Associated LipocalinTurkey
Clinical Trials on low AGE meal
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
University of AberdeenUniversity of DundeeCompleted
-
Federico II UniversityUnknown
-
Pennington Biomedical Research CenterCompletedDiabetes Mellitus, Type 2United States
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Completed
-
Ruhr University of BochumCompletedType 2 Diabetes Mellitus | Endothelial DysfunctionGermany
-
Ryerson UniversityCompletedObesity | OverweightCanada
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedMetabolic SyndromeUnited States